Allergy Testing Access Act of 2021

United States117th CongressHR-4114House of Representatives
Updated: Jun 25, 2021

Summary

Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-701: Allergy Testing Access Act of 2021

Read twice and referred to the Committee on Finance.

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Introduced in House

  4. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.